Psychiatric Disorders and Weight Change in a Prospective Study of Bariatric Surgery Patients: A 3-Year Follow-Up.

Psychosom Med

From the Duquesne University School of Nursing (Kalarchian), Pittsburgh, Pennsylvania; Department of Epidemiology (King), Department of Biostatistics (Chen), University of Pittsburgh, Pittsburgh, Pennsylvania; Columbia University College of Physicians and Surgeons/New York State Psychiatric Institute (Devlin), New York, New York; Department of Psychiatry, University of Pittsburgh School of Medicine (Marcus), Pittsburgh, Pennsylvania; Sanford Health System and the University of North Dakota School of Medicine and Health Sciences (Garcia), Grand Forks, North Dakota; Division of Digestive Diseases and Nutrition, National Institute of Diabetes and Digestive and Kidney Diseases (Yanovski), Bethesda, Maryland; and Neuropsychiatric Research Institute and the University of North Dakota School of Medicine and Health Sciences (Mitchell), Grand Forks, North Dakota.

Published: April 2016

Objectives: To document changes in Axis I psychiatric disorders after bariatric surgery and examine their relationship with postsurgery weight loss.

Methods: As part of a three-site substudy of the Longitudinal Assessment of Bariatric Surgery Research Consortium, 199 patients completed the Structured Clinical Interview for DSM-IV before Roux-en-Y gastric bypass or laparoscopic adjustable gastric band. At 2 or 3 years after surgery, 165 (83%) patients completed a follow-up assessment (presurgery median body mass index = 44.8 kg/m, median age = 46 years, 92.7% white, 81.1% female). Linear-mixed modeling was used to test change in prevalence of psychiatric disorders over time, report remission and incidence, and examine associations between psychiatric disorders and weight loss.

Results: Compared with status presurgery, the prevalence of any Axis I psychiatric disorder was significantly lower at 2 and 3 years after surgery (30.2% versus 16.8% [p = .003] and 18.4% [p = .012], respectively). Adjusting for site, age, sex, race, presurgery body mass index, and surgical procedure, presurgery mood, anxiety, eating or substance use disorders (lifetime or current) were not related to weight change, nor were postsurgery mood or anxiety disorders (p for all > .05). However, having a postsurgery eating disorder was independently associated with less weight loss at 2 or 3 years (β = 6.7%, p = .035).

Conclusions: Bariatric surgery was associated with decreases in psychiatric disorders through 3 years after surgery. Postsurgical eating disorders were associated with less weight loss after surgery, adding to the literature suggesting that disordered eating after surgery is related to suboptimal weight loss.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5041300PMC
http://dx.doi.org/10.1097/PSY.0000000000000277DOI Listing

Publication Analysis

Top Keywords

psychiatric disorders
20
bariatric surgery
16
years surgery
12
weight loss
12
surgery
9
disorders weight
8
weight change
8
axis psychiatric
8
patients completed
8
body mass
8

Similar Publications

Background: Attention-deficit/hyperactivity disorder (ADHD) is a common neuro-developmental disorder that often persists into adulthood. Moreover, it is frequently accompanied by bipolar disorder (BD) as well as borderline personality disorder (BPD). It is unclear whether these disorders share underlying pathomechanisms, given that all three are characterized by alterations in affective states, either long or short-term.

View Article and Find Full Text PDF

Autism spectrum disorder (ASD) involves challenges in communication and social interaction, including challenges in recognizing emotions. Existing technological solutions aim to improve social behaviors in individuals with ASD by providing learning aids. This paper presents a real-time environmental translator designed to enhance social behaviors in individuals with ASD using sensory substitution.

View Article and Find Full Text PDF

Alzheimer's disease (AD) is a severe neurodegenerative disease, and the most common type of dementia, with symptoms of progressive cognitive dysfunction and behavioral impairment. Studying the pathogenesis of AD and exploring new targets for the prevention and treatment of AD is a very worthwhile challenge. Accumulating evidence has highlighted the effects of fatty acid metabolism on AD.

View Article and Find Full Text PDF

Cannabis use disorder affects up to 42% of individuals with schizophrenia, correlating with earlier onset, increased positive symptoms, and more frequent hospitalizations. This study employed an untargeted lipidomics approach to identify biomarkers in plasma samples from subjects with schizophrenia, cannabis use disorder, or both (dual diagnosis), aiming to elucidate the metabolic underpinnings of cannabis abuse and schizophrenia development. The use of liquid chromatography-high resolution mass spectrometry enabled the annotation of 119 metabolites, with the highest identification confidence level achieved for 16 compounds.

View Article and Find Full Text PDF

Enhancing early detection of Alzheimer's disease through hybrid models based on feature fusion of multi-CNN and handcrafted features.

Sci Rep

December 2024

Department of Information and Computer Science, College of Computer Science and Engineering, University of Ha'il, Ha'il, 81481, Saudi Arabia.

Alzheimer's disease (AD) is a brain disorder that causes memory loss and behavioral and thinking problems. The symptoms of Alzheimer's are similar throughout its development stages, which makes it difficult to diagnose manually. Therefore, artificial intelligence (AI) techniques address the limitations of manual diagnosis.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!